↓ Skip to main content

Fluvoxamine for the treatment of COVID-19

Overview of attention for article published in Cochrane database of systematic reviews, September 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

blogs
1 blog
twitter
35 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Fluvoxamine for the treatment of COVID-19
Published in
Cochrane database of systematic reviews, September 2022
DOI 10.1002/14651858.cd015391
Pubmed ID
Authors

John LZ Nyirenda, Mario Sofroniou, Ingrid Toews, Agata Mikolajewska, Cornelius Lehane, Ina Monsef, Aesha Abu-taha, Andy Maun, Miriam Stegemann, Christine Schmucker

Twitter Demographics

The data shown below were collected from the profiles of 35 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 22 41%
Other 4 7%
Student > Bachelor 4 7%
Student > Master 3 6%
Student > Postgraduate 2 4%
Other 5 9%
Unknown 14 26%
Readers by discipline Count As %
Unspecified 22 41%
Medicine and Dentistry 14 26%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Immunology and Microbiology 1 2%
Environmental Science 1 2%
Other 2 4%
Unknown 13 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2023.
All research outputs
#1,275,570
of 22,977,819 outputs
Outputs from Cochrane database of systematic reviews
#2,930
of 12,337 outputs
Outputs of similar age
#27,963
of 431,882 outputs
Outputs of similar age from Cochrane database of systematic reviews
#37
of 127 outputs
Altmetric has tracked 22,977,819 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,337 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.7. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,882 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 127 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.